Calling attention to a podcast from Wilmer Eye – Diagnosis Glaucoma. Drs. Mona Kaleem and Harry Quigley talk with Dr. Gary Novack about the Drug Development Process for new pharmacological treatments for glaucoma. In episode 43, discussed are the development and FDA approval process of eye drop medications for glaucoma. Towards the end of the […]
Dr. Novack was selected to be a fellow of the Association for Ocular Pharmacology and Therapeutics. The Association for Ocular Pharmacology and Therapeutics is a global organization for scientists and individuals from all disciplines related to ocular pharmacology and its therapeutic applications. Fellows of AOPT are nominated by their peers based upon service to the […]
Dr. Novack gave a lecture at the Kellogg Eye Center of the School of Medicine at the University of Michigan. The topic was “Contaminated Eye Drops: What is going on”? He described the ongoing issue with contamination and infection, what to do for patients, and the impact of this issue on the larger field of […]
In this, my 40th ARVO annual meeting, I was able to share science, thoughtful discussions, and social encounters with friends and colleagues. While we are no longer on the beach in shorts, the spirit of Sarasota can still be seen in respectful, impactful discourse.
I call attention to this paper of mine just published in Eye & Contact Lens together with colleagues Drs. Kathryn Richdale, Erin Tomiyama and Mark Bullimore – a survey of the variability of atropine formulation, sterility and stability testing and storage requirements for compounded low dose atropine for myopia prevention. https://pubmed.ncbi.nlm.nih.gov/36083169/
Gary D. Novack, Ph..D. was honored by the American Academy of Ophthalmology (AAO). In the AAO’s honors for its 2022 Annual Meeting, Dr. Novack was cited by its Secretariat for his work on the Academy’s journal, Ophthalmology Glaucoma. Dr. Novack serves as both an author and reviewer for this journal.
Dr. Gary Novack presented an invited talk on “Why are there not more new glaucoma drugs” at the August meeting of the Glaucoma Research Society. The Glaucoma Research Society is a public interest, non-profit scientific association of outstanding glaucoma researchers that provides a forum to discuss and stimulate compelling or innovative research to prevent glaucoma-related […]
In May, Dr. Novack was part of a UC Davis Department of Ophthalmology & Vision Science weekend Continuing Medical Education course in Napa. He presented issues surrounding off-label use and compounded medications in ophthalmology. He also discussed generic vs. branded products.
Dr. Novack, served as a judge at the UC Davis Department of Ophthalmology & Visual Sciences annual trainee and alumni research day. It was a great day highlighting the quality of our trainees, faculty, alumni and guest speaker, George B. Bartley , M.D.
Dr. Novack was featured in a spotlight on ARVO members in a May 2022 posting of The Ophthalmologist entitled “Captain’s Log”, the reported focused on Dr. Novack’s answer to a query about an analogy for his work. Novack said “…like Captain James T. Kirk in the Star Trek Original Series “Corbomite Maneuver”, episode, I use […]